Laminate Medical Technologies Ltd.

Laminate Medical Technologies was founded in 2012 to develop solutions for the most significant challenges preventing fistula use in dialysis patients. Laminate’s flagship product, VasQTM External Support, was designed to address the high rate of primary fistula failure and repeat procedures experienced by hemodialysis patients. Primary fistula failure rates have been estimated as high as 60% with most patients requiring frequent additional procedures to make the fistula functional. However, clinical results have demonstrated fistulas treated with VasQ have a significantly greater probability for success in becoming functional without the need for additional procedures. The Laminate team is an assembly of experts from around the world spanning Israel, Europe and the United States. We are excited to build on the early success of VasQ to deliver it and other innovated solutions for fistulas to the global marketplace.